6,180 reports of this reaction
2.6% of all FLUOXETINE HYDROCHLORIDE reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for FLUOXETINE HYDROCHLORIDE, manufactured by Aurobindo Pharma Limited. There are 6,180 FDA adverse event reports linking FLUOXETINE HYDROCHLORIDE to HEADACHE. This represents approximately 2.6% of all 241,604 adverse event reports for this drug.
Patients taking FLUOXETINE HYDROCHLORIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for FLUOXETINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for FLUOXETINE HYDROCHLORIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 6,180 FDA reports for FLUOXETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.6% of all adverse event reports for FLUOXETINE HYDROCHLORIDE, making it a notable side effect.
If you experience headache while taking FLUOXETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.